Zobrazeno 1 - 7
of 7
pro vyhledávání: '"G. V. Volchenkov"'
Publikováno v:
Туберкулез и болезни лёгких, Vol 100, Iss 1, Pp 33-40 (2022)
The objective: to analyze and compare frequency and variety of adverse events (AEs) and their impact on outcomes of tuberculosis therapy when treating patients with multiple drug resistant tuberculosis (MDR TB) and different HIV statuses.Subjects and
Externí odkaz:
https://doaj.org/article/4cc4ad9c479a48bc8e0dc96430ab9b2c
Autor:
S. E. Borisov, E. M. Bogorodskaya, G. V. Volchenkov, E. V. Kulchavenya, A. O. Maryandyshev, S. N. Skornyakov, O. B. Talibov, A. M. Tikhonov, I. A. Vasilyeva
Publikováno v:
Туберкулез и болезни лёгких, Vol 96, Iss 3, Pp 6-18 (2018)
The objective of the study: to assess efficiency and safety of SQ109 used within standard treatment regimens for multiple drug resistant tuberculosis (MDR TB)Subjects and Methods A multi-center, double, blind, randomized, placebo-controlled study was
Externí odkaz:
https://doaj.org/article/95f3ca114ed944d7826a17058873f5b0
Publikováno v:
Туберкулез и болезни лёгких, Vol 95, Iss 5, Pp 18-23 (2017)
The current situation related to biosafety in bacteriological laboratories in the Russian TB units was comprehensively analyzed. Main problems promoting the increased risk of infection of laboratory personnel with tuberculous mycobacteria were detect
Externí odkaz:
https://doaj.org/article/66bf6d6350da40c68b5320683d32101a
Autor:
E. S. Dyuzhik, N. V. Kaunetis, T. G. Smirnova, E. E. Larionova, G. V. Volchenkov, L. N. Chernousova
Publikováno v:
Туберкулез и болезни лёгких, Vol 94, Iss 1, Pp 28-33 (2016)
In order to determine critical concentrations of the second line TB drugs, namely cycloserin and PAS, and to use these critical concentrations for establishment of drug susceptibility testing by the proportional method on the liquid medium of Middleb
Externí odkaz:
https://doaj.org/article/29b21e538f4a461cb21613a3142ccdd8
Publikováno v:
Туберкулез и болезни лёгких, Vol 0, Iss 10, Pp 36-41 (2015)
The study presents the analysis of drug susceptibility of tuberculosis mycobacteria isolated from pulmonary tuberculosis patients by the moment of their registration in 2013 on the territory of Vladimir region. Totally 574 pulmonary tuberculosis pati
Externí odkaz:
https://doaj.org/article/d3363f26fb874d72bdba51435baa213f
Autor:
I. A. Vasilieva, G. V. Volchenkov, Elena Larionova, N. V. Kaunetis, T. A. Kuznetsova, Larisa Chernousova, T. R. Somova, Sofya Andreevskaya, Vladislav V. Erokhin, Olga V. Demikhova, A. V. Vorobieva, Ekaterina V. Kurbatova, Julia Ershova, S. S. Zolkina, Smirnova Tg, Dorothy A. Kaminski, J. P. Cegielski
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 32:735-743
The purpose of this study was to assess the performance of Cepheid® Xpert MTB/RIF® ("Xpert") and TB-Biochip® MDR ("TB-Biochip"). Sputum specimens from adults with presumptive tuberculosis (TB) were homogenized and split for: (1) direct Xpert and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::016491fa354644d13b737fd981e63cdc
https://doi.org/10.1007/s10096-012-1798-0
https://doi.org/10.1007/s10096-012-1798-0
Autor:
V V, Punga, W M, Jakubowiak, I D, Danilova, T R, Somova, G V, Volchenkov, B Y, Kazionnyy, E S, Nemtsova, E V, Kiryanova, E V, Kourbatova
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 13(10)
Joint World Health Organization (WHO) projects in Vladimir and Orel regions, Russia.To study the prevalence of extensively drug-resistant (XDR) tuberculosis (TB).Drug susceptibility testing of second-line drugs (ofloxacin, kanamycin, capreomycin, eth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a0b36a5c9623313b54d16cd2cfda65e
https://pubmed.ncbi.nlm.nih.gov/19793439
https://pubmed.ncbi.nlm.nih.gov/19793439